Insilico Medicine's Series A - II Round

Insilico Medicine raised a round of funding on July 18, 2017. Investors include Jim Mellon.

Insilico Medicine aims to extend healthy longevity through innovative AI solutions for drug discovery and aging research. The company has developed a drug discovery engine, which utilizes millions of …

Articles about Insilico Medicine's Series A - II Round: